Litigation Details for Novartis Pharmaceuticals Corporation v. West-Ward Pharmaceuticals International-Limited (D. Del. 2014)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. West-Ward Pharmaceuticals International-Limited (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-09-16 |
| Court | District Court, D. Delaware | Date Terminated | 2019-03-14 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 6,004,973; 6,239,124; 6,455,518 | ||
| Link to Docket | External link to docket | ||
Details for Novartis Pharmaceuticals Corporation v. West-Ward Pharmaceuticals International-Limited (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-09-16 | 1 | United States Letters Patent No. 6,004,973 (“the ‘973 patent”). The ‘973 patent was duly and legally …United States Letters Patent No. 5,665,772 (“the ‘772 patent”). The ‘772 patent was duly and legally …United States Letters Patent No. 6,239,124 (“the ‘124 patent”). The ‘124 patent was duly and legally …United States Letters Patent No. 6,455,518 (“the ‘518 patent”). The ‘518 patent was duly and legally …772, ‘973, ‘124, and ‘518 patents was an act of infringement of those patents. 32. | External link to document | |
| 2016-09-26 | 169 | Of U.S. Patent No. 5,665,772 For Obviousness And The Invalidity Of U.S. Patent Nos. 6,239,124 and 6,455…For Obviousness and For Obviousness-Type Double Patenting, by Roxane Laboratories Inc.. (O'Byrne, Stephanie…2014 14 March 2019 1:14-cv-01196 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-10-17 | 177 | Brief Regarding Noninfringement of U.S. Patent Nos. 6,239,124 and 6,455,518, by Roxane Laboratories Inc…2014 14 March 2019 1:14-cv-01196 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
